For the first time ever, we have received radio signals from deep within Eden! It's not demons either, but our very own flesh and blood. That's right, we now can transmit radio deep into hell, so our Helix boys can scout the area and begin to bring us information from the depths Eden. The Thornspire Broadcast Station also includes a carving of the initials of those who set it up, and are as follows: I.W., R.F., E.T., and M.V., and we will never forget these heroes.
In other news, new potential applications of a new Eden fruit; Cyanine Jellies have been recently been discovered by a promising STEM student...
On March 14, 2018, a little-known company named Gen-Wyld announced FDA approval for a groundbreaking procedure to enhance a patient’s primary and secondary sexual characteristics using gene therapy. The company was an overnight success.
Shortly thereafter, they introduced a suite of gene-altering body modification procedures that allowed patients to make dramatic aesthetic changes to their bodies by gene-splicing “non-human” anatomy. Those daring (and wealthy) enough can now add cuttlefish pigmentation to their skin, sport a pair of fox ears, and even add a functional tail. While rare, these so-called “modders” draw plenty of hate from conservative communities.
Thanks to their revolutionary procedures, Gen-Wyld is now a household name. Norman Carlson, Gen-Wyld’s chief evangelist, recently announced the company is in the trial phase for a groundbreaking treatment for diabetes.
Yet despite their success, a shroud of secrecy surrounds Gen-Wyld. Their no-patent policy obscures the secrets of their procedures from the public eye. Financial experts claim that Gen-Wyld is run less like a traditional business and more like an NGO with some specific, unknown objective.
Some claim that they will not stop until humanity has been reduced to monstrous slaves and that Gen-Wyld’s board of directors will install themselves as inhuman overlords of the new world order.
However, until the true secrets behind Gen-Wyld are discovered, the genetic biotech firm will continue to grow, develop, and progress its grand designs.